These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 33596496

  • 1. Adverse events among adult Medicaid enrollees with opioid use disorder and co-occurring substance use disorders.
    O'Brien P, Henke RM, Schaefer MB, Lin J, Creedon TB.
    Drug Alcohol Depend; 2021 Apr 01; 221():108555. PubMed ID: 33596496
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.
    Ali MM, Cutler E, Mutter R, Henke RM, O'Brien PL, Pines JM, Mazer-Amirshahi M, Diou-Cass J.
    J Med Toxicol; 2019 Jul 01; 15(3):156-168. PubMed ID: 31152355
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
    Wei YJ, Chen C, Schmidt SO, LoCiganic WH, Winterstein AG.
    Drug Alcohol Depend; 2019 Nov 01; 204():107600. PubMed ID: 31586806
    [Abstract] [Full Text] [Related]

  • 8. Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk.
    Tardelli V, Xu KY, Bisaga A, Levin FR, Fidalgo TM, Grucza RA.
    BMJ Ment Health; 2023 Jul 01; 26(1):. PubMed ID: 37500184
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse.
    Swartz JA, Franceschini D, Scamperle K.
    AIMS Public Health; 2023 Jul 01; 10(3):658-677. PubMed ID: 37842281
    [Abstract] [Full Text] [Related]

  • 11. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
    Xu KY, Mintz CM, Presnall N, Bierut LJ, Grucza RA.
    JAMA Netw Open; 2022 May 02; 5(5):e2211363. PubMed ID: 35536575
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M, Talbert JC, Huang Z, Oser C, Freeman PR.
    Pain Physician; 2021 Mar 02; 24(2):E249-E256. PubMed ID: 33740362
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Opioid Use Disorder among Hospitalized Adults in North Carolina: Analysis from the 2000-2020 NC State Inpatient Database.
    Alemu BT, Beydoun HA, Olayinka O, Harmer B, Brown AR.
    South Med J; 2024 May 02; 117(5):226-234. PubMed ID: 38701842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.